Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop

Malaria Journal

Volumn 3, Issue , 2004, Pages 1-7

  Muhlberger N ^a   Jelinek, T ^a   Gascon, J ^b   Probst, M ^a   Zoller, T ^a   Schunk, M ^c   Beran, J ^d   Gjorup I ^e   Behrens, R H ^f   Clerinx, J ^g   Bjorkman A ^h   McWhinney, P ⁱ   Matteelli, A ^j   Lopez Velez, R ^k   Bisoffi, Z ^l   Hellgren, U ^m   Puente, S ⁿ   Schmid, M L ^o   Myrvang, B ^p   Holthoff Stich, M L ^q   Laferl, H ^r   Hatz, C ^s   Kollaritsch, H ^t   Kapaun, A ^u   Knobloch, J ^v   Iversen, J ^w   Kotlowski, A ^x   Malvy, D J M ^y   Kern, P ^z   Fry, G ^aa   Siikamaki, H ^ab   Schulze, M H ^ac   Soula, G ^ad   Paul, M ^ae   Gomez I Prat J ^af   Lehmann, V ^ag   Bouchaud, O ^ah   Da Cunha, S ^ai   Atouguia, J ^aj   Boecken, G ^ak   more..

^a HUMBOLDT UNIVERSITY   (Germany)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^g INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ BRADFORD ROYAL INFIRMARY   (United Kingdom)

^j UNIVERSITY OF BRESCIA   (Italy)

^k HOSPITAL RAMÓN Y CAJAL   (Spain)

^l Ospedale S Cuore   (Italy)

^m KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^o NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^p ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^q Missionsarztliche Klinik   (Germany)

^r Medizinische Abteilung mit Infektions und Tropenmedizin   (Austria)

^s SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^t UNIVERSITY OF VIENNA   (Austria)

^u UNIVERSITY OF HEIDELBERG   (Germany)

^v UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^w HVIDOVRE HOSPITAL   (Denmark)

^x MEDICAL UNIVERSITY OF GDANSK   (Poland)

^y HÔPITAL SAINT ANDRÉ   (France)

^z UNIVERSITY OF ULM   (Germany)

^aa Tropical Medical Bureau   (Ireland)

^ab HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ac Klinikum St Georg   (Germany)

^ad HÔPITAL NORD   (France)

^ae POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^af INSTITUT CATALÀ DE LA SALUT   (Spain)

^ag HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^ah AVICENNE HOSPITAL   (France)

^ai CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^aj UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^ak Schiffahrtmedizinisches Institut der Marine   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; DOXYCYCLINE; FANSIDAR; MEFLOQUINE; PRIMAQUINE; PROGUANIL; QUININE; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DISEASE COURSE; ENDEMIC DISEASE; EUROPE; FATIGUE; FEMALE; FEVER; GEOGRAPHIC DISTRIBUTION; HEADACHE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IMPORT DISEASE; INCUBATION TIME; INFECTION RATE; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MUSCULOSKELETAL DISEASE; PATIENT CODING; PATIENT COMPLIANCE; PLASMODIUM VIVAX; TRAVEL; TREATMENT PLANNING; ADULT; ANIMAL; CLINICAL TRIAL; ISOLATION AND PURIFICATION; MULTICENTER STUDY; PATHOLOGY; PLASMODIUM VIVAX MALARIA; SENTINEL SURVEILLANCE;

ADULT; ANIMALS; EUROPE; FEMALE; HUMANS; MALARIA, VIVAX; MALE; PLASMODIUM VIVAX; SENTINEL SURVEILLANCE; TRAVEL;

EID: 2642540200     PISSN: 14752875     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2875-3-1     Document Type: Article

References (36)

1. MendisK, SinaBJ, MarchesiniP, CarterR: The neglected burden of Plasmodium vivax malaria.Am J Trop Med Hyg2001, 64:97-106.
2. MillerLH, MasonSJ, ClydeDF, McGinnissMH: The resistance factor to Plasmodium vivaxin blacks. The Duffy-blood-group genotype, FyFy.N Engl J Med1976, 295:302-304.
3. MillerLH, BaruchDI, MarshK, DoumboOK: The pathogenic basis of malaria.Nature2002, 415:673-679.
4. WeatherallDJ, MillerLH, BaruchDI, MarshK, DoumboOK, Casals-PascualC, RobertsDJ: Malaria and the red cell.Hematology (Am Soc Hematol Educ Program)2002:35-57.
5. RidleyRG: Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?Proc Natl Acad Sci USA2002, 99:13362-133624.
6. KarunaweeraND, WijesekeraSK, WanasekeraD, MendisKN, CarterR: The paroxysm of Plasmodium vivax malaria.Trends Parasitol2003, 19:188-193.
7. KainKC, HarringtonMA, TennysonS, KeystoneJS: Imported malaria: prospective analysis of problems in diagnosis and management.Clin Infect Dis1998, 27:142-149.
8. FillerS, CauserLM, NewmanRD, BarberAM, RobertsJM, MacArthurJ, PariseME, SteketeeRW, DorseyG, GandhiM, OyugiJH, RosenthalPJ, RomiR, SabatinelliG, MajoriG, SvensonJE, MacLeanJD, GyorkosTW, KeystoneJ, JuckettG, BoccoliniD, KainKC, HarringtonMA, TennysonS, KeystoneJS: Malaria surveillance - United States, 2001. MMWR Surveill Summ2003, 52:1-14.
9. DanisM, LegrosF, ThellierM, CaumesE: Données actuelles sur le paludisme en France métropolitaine.Méd Trap (Mars)2002, 62:214-218.
10. SchwartzE, PariseM, KozarskyP, CetronM: Delayed onset of malaria - implications for chemoprophylaxis in travelers.N Engl J Med2003, 349:1510-1516.
11. BairdJK, RieckmannKH: Can primaquine therapy for vivax malaria be improved?Trends Parasitol2003, 19:115-120.
12. LegrosF, DanisM: Surveillance of malaria in European Union countries. Euro Surveill1998, 3:45-47.
13. RomiR, BoccoliniD, MajoriG: Malaria incidence and mortality in Italy in 1999-2000.Euro Surveill2001, 6:143-147.
14. StraussR, PfeiferC: Malaria in Austria 1990-2000.Euro Surveill2003, 8:91-96.
15. BradleyDJ, WarhurstDC, BlazeM, SmithV, WilliamsJ: Malaria imported into the United Kingdom in 1996.Euro Surveill1998, 3:40-42.
16. RKI: Reiseassoziierte Infektionskrankheiten in Deutschland 2001.Epidemiols Bull2002:285-296.
17. Overview of malaria notifications in the Netherlands, 1995-9. Eurosurveill Weekl2000, 4:38.
18. Malaria in Denmark, 1999.Eurosurveill Weekl2000, 4:38.
19. Imported malaria in Finland, 2001.Euro Surveill Weekl2002, 6:17.
20. LegrosF, GayF, BelkaidM, DanisM: Imported malaria in continental France in 1996.Euro Surveill1998, 3:37-38.
21. WHO: The use of antimalarial drugs - Report of an informal consultation (13 to 17 November 2000).2001:144.
22. KainKC, ShanksGD, KeystoneJS: Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.Clin Infect Dis2001, 33:226-234.
23. Canadian recommendations for the prevention and treatment of malaria among international travellers. Committee to Advise on Tropical Medicine and Travel (CATMAT), Laboratory for Disease Control.Can Commun Dis Rep2000, 26 Suppl 2(i-vi):1-42.
24. ArnoldJ, AlvingAS, HockwaldRS, ClaymanCB, DernRJ, BeutlerE, Flan-aganCL, JefferyGM: The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain).J Lab Clin Med1955, 46:391-397.
25. FryauffDJ, BairdJK, BasriH, SumawinataI, Purnomo, RichieTL, OhrtCK, MouzinE, ChurchCJ, RichardsAL, et al.: Randomised placebo-controlled trial of primaquine for prophylaxis of falci-parum and vivax malaria.Lancet1995, 346:1190-1193.
26. SotoJ, ToledoJ, RodriquezM, SanchezJ, HerreraR, PadillaJ, BermanJ: Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial.Ann Intern Med1998, 129:241-244.
27. BairdJK, LacyMD, BasriH, BarcusMJ, MaguireJD, BangsMJ, GramzinskiR, SismadiP, Krisin, LingJ, WiadyI, KusumaningsihM, JonesTR, FryauffDJ, HoffmanSL: Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.Clin Infect Dis2001, 33:1990-1997.
28. PaulMA, McCarthyAE, GibsonN, KennyG, CookT, GrayG: The impact of Malarone and primaquine on psychomotor performance.Aviat Space Environ Med2003, 74:738-745.
29. JuckettG: Malaria prevention in travelers.Review. Erratum In: Am Fam Physician2000, 61(1):2535-2536.
30. ShanksGD, KainKC, KeystoneJS: Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.Clin Infect Dis2001, 33:381-385.
31. PukrittayakameeS, ChantraA, SimpsonJA, VanijanontaS, ClemensR, LooareesuwanS, WhiteNJ: Therapeutic responses to different antimalarial drugs in vivax malaria.Antimicrob Agents Chemother2000, 44:1680-1685.
32. GogtayNJ, DesaiS, KamtekarKD, KadamVS, DalviSS, KshirsagarNA: Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections.Ann Trop Med Parasitol1999, 93:809-812.
33. JelinekT, NothdurftHD, Von SonnenburgF, LoscherT: Long-term efficacy of primaquine in the treatment of vivax malaria in nonimmune travelers.Am J Trop Med Hyg1995, 52:322-324.
34. da Silva RdoS, PintoAY, CalvosaVS, de SouzaJM: Esquemas terapêuticos encurtados para o tratament de malária por Plasmodium.Rev Soc Bras Med Trop2003, 36:235-239.
35. YadavRS, GhoshSK: Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.J Parasitol2002, 88:1042-1044.
36. NicolasX, GranierH, LabordeJP, TalarminF, KlotzF: Plasmodium vivax: actualités thérapeutiques.Presse Méd2001, 30:767-771.